Access LAI Toolkits/Resources
LAI Administration Videos
LAI Administrative Toolkit
Sign in to register for all FREE!

Expand Access to LAIs, Expand Care

Pharmacists can play an instrumental role in the administration of psychotropic long-acting injectable (LAI) medications (antipsychotics, naltrexone, buprenorphine) but may lack the training needed to perform this important service. This multi-faceted, on demand educational activity aims to reduce barriers and increase patient access to LAIs through a universal training program that includes, but is not limited to, appropriate patient selection, LAI preparation and administration techniques, and insights into methods to engage a patient population with serious mental illness.

Disclosure on State Training Requirements

The ability of a pharmacist to administer injectable medications is based on individual state regulations. Each state has its own unique LAI training requirements. Please review the regulations for the state you practice in to determine whether the program meets your needs and whether additional training beyond this program is required prior to administering LAI medications to patients.

Order a print copy of the pocket guide!

Download a certificate of completion after completing all 6 modules.

View AAPP's Advanced Track Psychotropic Long-Acting Injectable Program

Be Prepared for LAI Administration

This ACPE approved educational activity includes 5 hours of on demand recorded webinars on psychotropic LAI patient selection, pharmacology, dosing, preparation/administration/storage, key adverse effects and mitigation strategies, and building an LAI practice. Videos on LAI administration are incorporated into the curriculum to enhance learning and real-life application.

***Note: Indivior discontinued the sales of Perseris® effective July 9, 2024. Perseris® is included in course materials to accommodate facilities that are still using the remaining supply of this product and for historical reference purposes. While Perseris® may no longer be commercially available, its inclusion in the course is intended to provide comprehensive education.

Introduction to Long-Acting Injectables and Patient Selection

Samantha Catanzano, PharmD, BCPP
Clinical Assistant Professor
The University of Texas at Austin College of Pharmacy
Austin, TX

Antipsychotic Long-Acting Injectable Pharmacology and Dosing

Megan Ehret, PharmD, MS, BCPP
Professor
University of Maryland
Baltimore, MD

Antipsychotic Long-Acting Injectable Preparation, Administration, and Storage

Christine Rarrick, MBA, PharmD, BCPP, BCPS
Clinical Pharmacy Specialist
MUSC
Charleston, SC

Antipsychotic Long-Acting Injectable Adverse Effects, Mitigation Strategies, and Monitoring

Chris Paxos, PharmD, BCPP, BCGP, BCPS
Professor, Pharmacy Practice
Northeast Ohio Medical University
Rootstown, OH

Substance Use Disorder Long-Acting Injectables: Naltrexone and Buprenorphine

Benjamin Miskle, MBA, PharmD
Clinical Assistant Professor/Clinical Pharmacy Specialist
University of Iowa
Iowa City, IA

Building a Long-Acting Injectable Practice

Jerry McKee, PharmD, MS, BCPP
CEO
Psychopharm Solutions LLC
Morganton, NC

Updates to the Psychotropic Long-Acting Injectable Training Program

Megan Ehret, PharmD, MS, BCPP
Professor
University of Maryland
Baltimore, MD

This activity is supported by educational grants from Alkermes Inc., Indivior Inc., and Janssen Scientific Affairs, LLC.

Courses

TitleHoursRegister
Introduction to Long-Acting Injectable Antipsychotics and Patient Selection ACPE
This webinar reviews the signs, symptoms, and diagnostic criteria for serious mental illnesses; guideline recommendations for LAI ...[more]

This webinar reviews the signs, symptoms, and diagnostic criteria for serious mental illnesses; guideline recommendations for LAI antipsychotic use; the barriers, advantages, and disadvantages for the use of LAIs; and the role of the pharmacist in LAI administration in the pharmacy setting.

This is one of six modules in the Psychotropic LAI Training Program. Complete your complimentary registration now to access this module, 5 other ACPE approved modules, a LAI Pocket Guide, administration videos, and an Administrative Toolkit.

learn more

0.5View Purchase Options
Antipsychotic Long-Acting Injectable Pharmacology and Dosing ACPE
This webinar summarizes the approved indications, mechanisms of action, key pharmacokinetic considerations, oral supplementation ...[more]

This webinar summarizes the approved indications, mechanisms of action, key pharmacokinetic considerations, oral supplementation requirements, dosing and administration schedules, and missed dose management for LAI antipsychotics.

learn more

1View Purchase Options
Antipsychotic Long-Acting Injectable Preparation, Administration, and Storage ACPE
This webinar highlights key considerations for antipsychotic LAI preparation, administration, storage, and patient privacy. Videos ...[more]

This webinar highlights key considerations for antipsychotic LAI preparation, administration, storage, and patient privacy. Videos on LAI administration are incorporated in the presentation to help learners visualize appropriate injection techniques and locations.

learn more

1View Purchase Options
Antipsychotic Long-Acting Injectable Adverse Effects, Mitigation Strategies, and Monitoring ACPE
This webinar reviews the contraindications, warnings/precautions, common adverse effects, adverse effect mitigation strategies, and ...[more]

This webinar reviews the contraindications, warnings/precautions, common adverse effects, adverse effect mitigation strategies, and monitoring recommendations for LAI antipsychotics.

learn more

0.75View Purchase Options
Substance Use Disorder Long-Acting Injectables: Naltrexone and Buprenorphine ACPE
This webinar focuses on important factors related to use of LAIs for substance use disorders, such as target patient populations, ...[more]

This webinar focuses on important factors related to use of LAIs for substance use disorders, such as target patient populations, indications, product preparation, dosing, administration techniques, adverse effects, storage requirements, and monitoring recommendations.

learn more

0.75View Purchase Options
Building a Long-Acting Injectable Practice ACPE
The content in this webinar assists with building and expanding LAI clinics by outlining policies and procedures for administering ...[more]

The content in this webinar assists with building and expanding LAI clinics by outlining policies and procedures for administering LAIs; logistic considerations related to the location, room, and supplies; billing challenges and opportunities; marketing tips; and patient communication techniques.

learn more

1View Purchase Options
Updates to the Psychotropic Long-Acting Injectable Training Program
This webinar summarizes psychotropic long-acting injectable medications that have been approved since the launch of the program in ...[more]

This webinar summarizes psychotropic long-acting injectable medications that have been approved since the launch of the program in 2023 and were not included in the original presentations.

This presentation contains bonus material and NO ACPE credit is associated with this specific activity. Complete your complimentary registration now to access this presentation, 6 other ACPE approved modules, a LAI Pocket Guide, administration videos, and an Administrative Toolkit.

learn more

View Purchase Options